ILX Stock Overview
Ilex Medical Ltd markets, sells, and supports equipment, disposables, and reagents for laboratories and healthcare companies in Israel and South Africa.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Ilex Medical Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪67.82 |
| 52 Week High | ₪83.00 |
| 52 Week Low | ₪53.52 |
| Beta | -0.11 |
| 1 Month Change | 9.02% |
| 3 Month Change | 11.62% |
| 1 Year Change | -12.83% |
| 3 Year Change | -31.36% |
| 5 Year Change | 5.05% |
| Change since IPO | 2,033.45% |
Recent News & Updates
Recent updates
Ilex Medical Ltd (TLV:ILX) Investors Are Less Pessimistic Than Expected
Jan 02
Ilex Medical (TLV:ILX) Could Easily Take On More Debt
Feb 13The Trend Of High Returns At Ilex Medical (TLV:ILX) Has Us Very Interested
Nov 25Returns On Capital Are A Standout For Ilex Medical (TLV:ILX)
Jun 03Here's Why We Think Ilex Medical (TLV:ILX) Is Well Worth Watching
May 04Ilex Medical (TLV:ILX) Could Easily Take On More Debt
Apr 02Is It Smart To Buy Ilex Medical Ltd (TLV:ILX) Before It Goes Ex-Dividend?
Mar 20Ilex Medical (TLV:ILX): Are Investors Overlooking Returns On Capital?
Mar 02Are Robust Financials Driving The Recent Rally In Ilex Medical Ltd's (TLV:ILX) Stock?
Feb 16
What Type Of Shareholders Make Up Ilex Medical Ltd's (TLV:ILX) Share Registry?
Feb 04Here's Why I Think Ilex Medical (TLV:ILX) Is An Interesting Stock
Jan 24Shareholders of Ilex Medical (TLV:ILX) Must Be Delighted With Their 333% Total Return
Jan 11Ilex Medical (TLV:ILX) Has A Rock Solid Balance Sheet
Dec 23What Can We Make Of Ilex Medical's (TLV:ILX) CEO Compensation?
Nov 28Shareholder Returns
| ILX | IL Healthcare | IL Market | |
|---|---|---|---|
| 7D | -0.09% | -2.2% | 0.3% |
| 1Y | -12.8% | 7.7% | 11.6% |
Return vs Industry: ILX underperformed the IL Healthcare industry which returned 7.1% over the past year.
Return vs Market: ILX underperformed the IL Market which returned 9.8% over the past year.
Price Volatility
| ILX volatility | |
|---|---|
| ILX Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 4.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.4% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: ILX has not had significant price volatility in the past 3 months.
Volatility Over Time: ILX's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 223 | Tammy Galili | www.ilexmedical.com |
Ilex Medical Ltd markets, sells, and supports equipment, disposables, and reagents for laboratories and healthcare companies in Israel and South Africa. The company offers in vitro diagnostic equipment and reagent systems to hospitals, clinics, and other medical institutions; molecular biology products for cancer screening, retro virus viral load, TB, STDs, and other infectious diseases; and equipment, disposables, and reagents for in vitro fertilization, as well as food and pharma industries. It also distributes and supports nucleic acid testing blood screening solutions to large-scale blood banks; provides pre/post analytics and robotics; and develops, markets, implements, and supports advanced laboratory information systems.
Ilex Medical Ltd Fundamentals Summary
| ILX fundamental statistics | |
|---|---|
| Market cap | ₪765.05m |
| Earnings (TTM) | ₪50.89m |
| Revenue (TTM) | ₪930.89m |
15.0x
P/E Ratio0.8x
P/S RatioIs ILX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ILX income statement (TTM) | |
|---|---|
| Revenue | ₪930.89m |
| Cost of Revenue | ₪699.02m |
| Gross Profit | ₪231.87m |
| Other Expenses | ₪180.98m |
| Earnings | ₪50.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.51 |
| Gross Margin | 24.91% |
| Net Profit Margin | 5.47% |
| Debt/Equity Ratio | 0.1% |
How did ILX perform over the long term?
See historical performance and comparison